2. Academic Validation
  3. Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB

Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB

  • Cell Chem Biol. 2023 Apr 20;30(4):394-402.e9. doi: 10.1016/j.chembiol.2023.02.008.
Elizabeth A King 1,  Yoojin Cho 1,  Nathan S Hsu 1,  Dustin Dovala 2,  Jeffrey M McKenna 3,  John A Tallarico 3,  Markus Schirle 3,  Daniel K Nomura 4
Affiliations

Affiliations

  • 1 Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA; Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, CA 94720, USA; Innovative Genomics Institute, Berkeley, CA 94704, USA.
  • 2 Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, CA 94720, USA; Novartis Institutes for BioMedical Research, Emeryville, CA 94608, USA.
  • 3 Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, CA 94720, USA; Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
  • 4 Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720, USA; Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, CA 94720, USA; Innovative Genomics Institute, Berkeley, CA 94704, USA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA. Electronic address: [email protected].
PMID: 36898369 DOI: 10.1016/j.chembiol.2023.02.008
Abstract

Targeted protein degradation has arisen as a powerful therapeutic modality for degrading disease targets. While proteolysis-targeting chimera (PROTAC) design is more modular, the discovery of molecular glue degraders has been more challenging. Here, we have coupled the phenotypic screening of a covalent ligand library with chemoproteomic approaches to rapidly discover a covalent molecular glue degrader and associated mechanisms. We have identified a cysteine-reactive covalent ligand EN450 that impairs leukemia cell viability in a NEDDylation and proteasome-dependent manner. Chemoproteomic profiling revealed covalent interaction of EN450 with an allosteric C111 in the E2 ubiquitin-conjugating Enzyme UBE2D. Quantitative proteomic profiling revealed the degradation of the oncogenic transcription factor NFKB1 as a putative degradation target. Our study thus puts forth the discovery of a covalent molecular glue degrader that uniquely induced the proximity of an E2 with a transcription factor to induce its degradation in Cancer cells.

Keywords

E2 ligase; NFKB1; UBE2D; activity-based protein profiling; molecular glue; targeted protein degradation; transcription factor.

Figures
Products